title: Antifungal activity of 2α,3β-functionalized steroids stereoselectively increases with the addition of oligosaccharides.
abstract: Invasive fungal infections pose a significant problem to the immune-compromised. Moreover, increased resistance to common antifungals requires development of novel compounds that can be used to treat invasive fungal infections. Naturally occurring steroidal glycosides have been shown to possess a range of functional antimicrobial properties, but synthetic methodology for their development hinders thorough exploration of this class of molecules and the structural components required for broad spectrum antifungal activity. In this report, we outline a novel approach to the synthesis of glycoside-linked functionalized 2α,3β-cholestane and spirostane molecules and present data from in vitro screenings of the antifungal activities against human fungal pathogens and as well as mammalian cell toxicity of these derivatives.
authors: Department of Pharmacology and Experimental Therapeutics, LSUHSC, 1901 Perdido St. New Orleans, LA 70112, USA.
authors: Amy
authors: A
authors: Cammarata
authors: Sunil Kumar
authors: SK
authors: Upadhyay
authors: Branko S
authors: BS
authors: Jursic
authors: Donna M
authors: DM
authors: Neumann
mesh_terms: D000935:Antifungal Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D002776:Cholestanes / Q000737:chemistry; D005658:Fungi / Q000187:drug effects; D006027:Glycosides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009844:Oligosaccharides / Q000737:chemistry*; D013150:Spirostans / Q000737:chemistry; D013237:Stereoisomerism; D013256:Steroids / Q000737:chemistry*
chemical_list: D000935:Antifungal Agents; D002776:Cholestanes; D006027:Glycosides; D009844:Oligosaccharides; D013150:Spirostans; D013256:Steroids